Antitrust Chronicle® – Patents, Drugs & Antitrust
Spring 2014, Volume 4, Number 2
Dear Readers, This issue looks at four health issues recently argued by the FTC. First, we deal with the FDA’s REMS (risk evaluation and mitigation strategies) program and how it seems to conflict with the FTC’s desire to encourage generic competition. The FTC is examining branded pharmaceutical firms’ refusal to sell samples of restricted distribution […]
In this issue
Oct 1, 2021
Dec 22, 2015
Apr 29, 2014
Apr 29, 2014
Apr 29, 2014
Apr 29, 2014
Apr 29, 2014
Apr 29, 2014
Apr 29, 2014
In case you missed it...

April
This Chronicle explores the rapidly evolving intersection of foreign direct investment and technology, a space where traditional assumptions about openness, control, and market integration are being fundamentally reworked.

March
This Chronicle brings together contributions that explore the evolving relationship between industrial policy, competition, regulation & technological change from complementary angles.

February
This month’s TechREG Chronicle focuses on online consumer protection, at a moment when regulators on both sides of the Atlantic are reassessing how legacy consumer-protection frameworks apply in digital, data-driven markets.
See more Chronicles by year:
Featured News
California Pushing Back Against Federal Preemption of Its Privacy Laws
May 7, 2026 by
CPI
Rave Sues Apple in Antitrust Case Over App Store Removal
May 7, 2026 by
CPI
Trivago Files Antitrust Case Against Google in Germany Over Search Practices
May 7, 2026 by
CPI
A New Idea Is Gaining Ground: Tax AI Computing Power to Offset Job Losses
May 7, 2026 by
CPI
Morocco Competition Authority Opens Antitrust Probe Into Luxury Beauty Market
May 7, 2026 by
CPI